Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 18/20 | 0.69 |
| ▸ | INSR | P06213 | 8/20 | 0.69 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.69 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.50 |
| ▸ | IGF1R | P08069 | 1/20 | 0.48 |
| ▸ | ROS1 | P08922 | 2/20 | 0.48 |
| ▸ | EGFR | P00533 | 1/20 | 0.48 |
| ▸ | MET | P08581 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL884865 | 0.96 | ALK (0.74) | ALKINSRKCNH2CYP3A4CYP2C9 | |
| SCHEMBL2942776 | 0.86 | ALK (0.91) | ALKINSRKCNH2CYP3A4CYP2C9 | |
| SCHEMBL2938657 | 0.85 | ALK (0.59) | ALKINSRKCNH2CYP3A4CYP2C9 | |
| SCHEMBL885571 | 0.84 | ALK (0.72) | ALKINSRKCNH2CYP3A4CYP2C9 | |
| SCHEMBL2943293 | 0.84 | ALK (0.73) | ALKINSRKCNH2CYP3A4CYP2C9 | |
| SCHEMBL886174 | 0.82 | ALK (1.00) | ALKINSRKCNH2CYP3A4CYP2C9 | |
| SCHEMBL2062478 | 0.82 | ALK (0.86) | ALKINSRKCNH2CYP3A4CYP2C9 | |
| SCHEMBL886716 | 0.82 | ALK (1.00) | ALKINSRKCNH2CYP3A4CYP2C9 | |
| SCHEMBL886352 | 0.81 | ALK (1.00) | ALKINSRKCNH2CYP3A4CYP2C9 | |
| SCHEMBL886118 | 0.81 | ALK (0.87) | ALKINSRKCNH2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2222647-A1 | FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS | Cephalon, Inc. (US) | 2010-09-01 | — | — | EP | disclosed |
| WO-2008051547-A1 | FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS | CEPHALON, INC. (US) | 2008-05-02 | — | — | WO | disclosed |